mitomycin has been researched along with carmofur in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (50.00) | 18.7374 |
| 1990's | 9 (32.14) | 18.2507 |
| 2000's | 5 (17.86) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amano, H; Awano, T; Funami, Y; Koide, Y; Matsubara, H; Matsushita, K; Nakaichi, H; Ochiai, T; Okuyama, K; Tohnosu, N | 1 |
| Akiyama, S; Ito, A; Ito, K; Kondo, K; Satta, T; Takagi, H; Watanabe, T; Yamauchi, M | 1 |
| Chang, YC; Kohno, H; Nagasue, N; Nakamura, T; Ogawa, Y; Sasaki, K; Takahashi, M; Yukaya, H | 1 |
| Hojo, K; Makuuchi, M; Moriya, Y; Sugihara, K | 1 |
| Katsuki, Y; Nishimura, A; Tsuji, Y; Yasuda, T | 1 |
| Abe, O; Hattori, T; Kikuchi, K; Komi, N; Kondo, T; Kunii, Y; Nakajima, T; Nakazato, H; Taguchi, T; Tanabe, T | 1 |
| Kimura, T; Kusama, S; Morioka, Y; Muto, T; Ogawa, N; Tomiyama, J | 1 |
| Itoh, A; Kitai, S; Sawai, K; Seiki, K; Shimamura, Y; Shimotsuma, M; Shioaki, Y; Takahashi, T; Taniguchi, H; Yamaguchi, T | 1 |
| Abe, M; Hirai, K; Kawazoe, Y; Kumagai, M; Tanikawa, K; Yamashita, K | 1 |
| Ichihashi, H; Koike, A; Nakazato, H | 1 |
| Ichihashi, H; Imaizumi, M; Kondo, T; Takagi, H; Terabe, K; Watanabe, T; Yamauchi, M | 1 |
| Nakanishi, Y | 1 |
| Hattori, T; Inokuchi, K; Niimoto, M; Ogawa, N; Sugimachi, K; Tamada, R | 1 |
| Ichihashi, H; Kondo, T; Takagi, H; Watanabe, T; Yamauchi, M | 1 |
| Anai, H; Kusumoto, H; Kusumoto, T; Maehara, Y; Sugimachi, K | 1 |
| Ichihashi, H; Koike, A; Nakazato, H; Yamamura, Y | 1 |
| Akiharu, W; Fujiwara, M; Higashi, T; Ito, T; Kobayashi, M; Nagashima, H; Nakatsukasa, H; Shiota, T; Yamamoto, H; Yamauchi, Y | 1 |
| Ichijo, M; Kamamoto, Y; Kosakai, H; Nakanishi, A; Noda, T; Shimamoto, I; Shintani, M; Tsujimura, K | 1 |
| Itsubo, M | 1 |
| Ito, K; Kato, T; Koike, A; Miura, K; Takagi, H; Yamaguchi, A | 1 |
| Fujisawa, J; Kondo, Y; Miyakawa, K; Nakanishi, Y; Nishimura, A; Oku, T; Osawa, S; Shiroto, H; Uchino, J | 1 |
| Hojo, K; Ichihashi, H; Kato, T; Kikuchi, K; Kodaira, S; Kunii, Y; Ogawa, M; Takahashi, T; Tamada, R; Tominaga, T; Yasutomi, M | 1 |
| Ishikawa, H; Iwasaki, Y; Kanazawa, K; Kitajima, M; Kodaira, S; Kotake, K; Koyama, Y; Miyata, M; Nagamachi, Y; Omoto, R; Shida, S; Tajima, Y; Tamakuma, S | 1 |
| Burzykowski, T; Buyse, M; Hamada, C; Ohashi, Y; Piedbois, P; Sakamoto, J | 1 |
| Hojyo, K; Isomoto, H; Kato, T; Kodaira, S; Kunii, Y; Kunitomo, K; Niimoto, M; Nishida, O; Ohashi, Y; Takahashi, T; Tominaga, T; Watanabe, M; Yasutomi, M | 1 |
| Amano, T; Hiki, Y; Kumada, K; Mitomi, T; Nishiyama, K; Noto, T; Ogawa, N; Oka, H; Oki, S; Otani, Y; Sadahiro, S; Takahashi, T; Takemiya, S; Tsuchiya, S; Yamakawa, T; Yamamura, T | 1 |
| Hojo, K; Isomoto, H; Kato, T; Kodaira, S; Kunitomo, K; Ohashi, Y; Takahashi, T; Tominaga, T; Watanabe, M; Yasutomi, M | 1 |
1 review(s) available for mitomycin and carmofur
| Article | Year |
|---|---|
Efficacy of oral adjuvant therapy after resection of colorectal cancer: 5-year results from three randomized trials.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Female; Fluorouracil; Humans; Male; Maximum Tolerated Dose; Mitomycin; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Randomized Controlled Trials as Topic; Rectal Neoplasms; Survival Rate; Tegafur | 2004 |
18 trial(s) available for mitomycin and carmofur
| Article | Year |
|---|---|
[Oral administration of 1-hexylcarbamoyl-5-fluorouracil (HCFU) in repeated arterial bolus chemotherapy in metastatic liver cancer of humans--preliminary randomized trial].
Topics: Administration, Oral; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Prospective Studies | 1991 |
[Mitomycin C plus HCFU adjuvant chemotherapy for noncuratively resected cases of colorectal carcinoma. (Second report): 5-year survival rate. Cooperative Study Group of Kyushu and Chugoku for HCFU Adjuvant Chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Combined Modality Therapy; Fluorouracil; Humans; Japan; Mitomycin; Mitomycins; Multicenter Studies as Topic; Prognosis; Prospective Studies; Random Allocation | 1989 |
[Adjuvant chemotherapy for gastric cancer--the third study. First report: central randomization by telephone method and analysis of patients' background factors].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Drug Administration Schedule; Fluorouracil; Humans; Japan; Mitomycin; Mitomycins; Multicenter Studies as Topic; Picibanil; Random Allocation; Stomach Neoplasms; Tegafur; Telephone | 1989 |
[Outcome of adjuvant mifurol chemotherapy in patients with resected colonic carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Combined Modality Therapy; Drug Evaluation; Female; Fluorouracil; Follow-Up Studies; Humans; Japan; Male; Middle Aged; Mitomycin; Mitomycins; Multicenter Studies as Topic; Tegafur | 1989 |
[A randomized controlled trial comparing short-term MF chemotherapy with MF and long-term carmofur chemotherapy as an adjuvant to curative resection of stomach cancer].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Drug Administration Schedule; Fluorouracil; Humans; Mitomycin; Mitomycins; Postoperative Period; Prognosis; Random Allocation; Stomach Neoplasms | 1986 |
[Prospective adjuvant chemotherapy, with mitomycin C plus long-term carmofur in colorectal cancer].
Topics: Antineoplastic Agents; Colonic Neoplasms; Combined Modality Therapy; Drug Administration Schedule; Drug Evaluation; Fluorouracil; Humans; Mitomycin; Mitomycins; Postoperative Care; Random Allocation; Rectal Neoplasms | 1986 |
[A randomized controlled trial of immunochemotherapy using carmofur (HCFU), mitomycin C and immunopotentiators in advanced gastric cancer following noncurative resection and nonresection].
Topics: Adjuvants, Immunologic; Adult; Aged; Clinical Trials as Topic; Drug Administration Schedule; Female; Fluorouracil; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Random Allocation; Stomach Neoplasms | 1986 |
Mitomycin C plus carmofur (HCFU) adjuvant chemotherapy for noncuratively resected cases of colorectal carcinoma (interim report).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Combined Modality Therapy; Fluorouracil; Humans; Mitomycin; Mitomycins; Prospective Studies; Random Allocation; Rectal Neoplasms | 1987 |
[Prospective adjuvant chemotherapy of mitomycin C plus HCFU for colorectal cancer (2d report)--6-year survival after surgery: Tokai Cooperative Study Group of Surgical Adjuvant Chemotherapy].
Topics: Adjuvants, Immunologic; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Colectomy; Colonic Neoplasms; Combined Modality Therapy; Fluorouracil; Humans; Mitomycin; Mitomycins; Postoperative Care; Rectal Neoplasms | 1988 |
[A randomized controlled trial comparing short-term MF chemotherapy with MF plus long-term HCFU chemotherapy as an adjuvant to a curative resection of stomach cancer: Mifurol Study Group for Stomach Cancer].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Clinical Trials as Topic; Drug Administration Schedule; Fluorouracil; Gastrectomy; Humans; Mitomycin; Mitomycins; Postoperative Care; Random Allocation; Stomach Neoplasms | 1988 |
[Clinical trial of carmofur (HCFU) in the treatment of malignant ovarian cancer--The first report: combination therapy with endoxan, mitomycin C, and toyomycin].
Topics: Adult; Aged; Antineoplastic Agents; Chromomycin A3; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Hysterectomy; Mitomycin; Mitomycins; Ovarian Neoplasms | 1983 |
Prospective adjuvant therapy with mitomycin C and carmofur (HCFU) for colorectal cancer, 10-year follow-up: Tokai HCFU Study Group, the first study for colorectal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Combined Modality Therapy; Female; Fluorouracil; Follow-Up Studies; Humans; Japan; Male; Middle Aged; Mitomycin; Prospective Studies; Survival Rate | 1996 |
[Randomized controlled study on adjuvant immunochemotherapy with carmofur (HCFU) for noncuratively resected and unresected gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Chi-Square Distribution; Combined Modality Therapy; Fluorouracil; Follow-Up Studies; Humans; Immunotherapy; Japan; Mitomycin; Picibanil; Stomach Neoplasms | 1996 |
[Prospective controlled study on the usefulness of Carmofur as a postoperative adjuvant chemotherapy for colorectal cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Drug Administration Schedule; Female; Fluorouracil; Humans; Lymphatic Metastasis; Male; Mitomycin; Neoplasm Invasiveness; Postoperative Care; Prospective Studies; Rectal Neoplasms; Survival Rate | 1997 |
[Neo-adjuvant chemotherapy with carmofur for colorectal cancer--a multi-institutional randomized controlled study].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Administration Schedule; Female; Fluorouracil; Humans; Male; Middle Aged; Mitomycin; Neoadjuvant Therapy; Neoplasm Staging; Preoperative Care; Prospective Studies; Survival Rate | 2002 |
Randomized controlled trial of the efficacy of adjuvant immunochemotherapy and adjuvant chemotherapy for colorectal cancer, using different combinations of the intracutaneous streptococcal preparation OK-432 and the oral pyrimidines 1-hexylcarbamoyl-5-flu
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colectomy; Colonic Neoplasms; Drug Combinations; Female; Fluorouracil; Humans; Injections, Subcutaneous; Male; Middle Aged; Mitomycin; Neoplasm Staging; Picibanil; Pyrimidines; Radiotherapy, Adjuvant; Rectal Neoplasms; Survival Analysis; Tegafur; Treatment Outcome; Uracil | 2004 |
[Multicenter comparative study of the recurrence-inhibitory effect of oral fluoropyrimidine drugs in patients with colorectal cancer following curative resection].
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Colectomy; Colonic Neoplasms; Combined Modality Therapy; Disease-Free Survival; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Humans; Leukopenia; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Rectal Neoplasms; Survival Rate; Tegafur; Uracil | 2005 |
Randomized trial of the efficacy of adjuvant chemotherapy for colon cancer with combination therapy incorporating the oral pyrimidine 1-hexylcarbamoyl-5-fluorouracil.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Combined Modality Therapy; Disease-Free Survival; Fluorouracil; Humans; Liver Neoplasms; Middle Aged; Mitomycin; Neoplasm Staging; Survival Rate; Treatment Outcome | 2006 |
9 other study(ies) available for mitomycin and carmofur
| Article | Year |
|---|---|
[Signification of liver metastases of colorectal cancer with special reference to recurrence in the residual liver after hepatic resection].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Doxorubicin; Drug Administration Schedule; Fluorouracil; Hepatectomy; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Mitomycin; Neoplasm Recurrence, Local | 1992 |
Subrenal capsule assay using nude mice as a predictor of the response of the gastric cancer to chemotherapy.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Drug Screening Assays, Antitumor; Fluorouracil; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Mitomycin; Mitomycins; Neoplasm Transplantation; Stomach Neoplasms; Subrenal Capsule Assay | 1991 |
Adjuvant hepatic intra-arterial chemotherapy after potentially curative hepatectomy for liver metastases from colorectal cancer: a pilot study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Female; Fluorouracil; Hepatectomy; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Pilot Projects; Survival Rate | 1991 |
[Evaluation of intraperitoneal cancer chemotherapy using an implantable reservoir in patients with peritonitis carcinomatosa].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Ascitic Fluid; Cisplatin; Colorectal Neoplasms; Evaluation Studies as Topic; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Male; Middle Aged; Mitomycin; Mitomycins; Peritonitis; Prognosis; Stomach Neoplasms; Tegafur | 1990 |
[Trans-arterial embolization or transarterial infusion of anti-cancer drugs suspended in a lipid contrast medium against unresectable metastatic liver cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Embolization, Therapeutic; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Iodized Oil; Liver Neoplasms; Maleic Anhydrides; Mitomycin; Mitomycins; Polystyrenes; Prognosis; Suspensions; Zinostatin | 1988 |
[One-shot therapy and transcatheter arterial embolization (TAE) therapy of unresectable hepatocellular carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Doxorubicin; Embolization, Therapeutic; Female; Fluorouracil; Hepatic Artery; Humans; Injections, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins | 1985 |
Colorectal carcinoma in vitro is more sensitive to 1-hexylcarbamoyl-5-fluorouracil compared with six other antitumor drugs: carboquone, Adriamycin, mitomycin C, aclacinomycin A, cisplatin, 5-fluorouracil.
Topics: Aclarubicin; Antineoplastic Agents; Carbazilquinone; Cisplatin; Colonic Neoplasms; Doxorubicin; Drug Screening Assays, Antitumor; Fluorouracil; Humans; In Vitro Techniques; Mitomycin; Mitomycins; Naphthacenes; Rectal Neoplasms; Succinate Dehydrogenase | 1988 |
[Role of oral administration of 1-hexyl-carbamoyl-5-fluorouracil (HCFU) for multimodal treatment of inoperable cirrhotics with hepatocellular carcinoma].
Topics: Administration, Oral; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Fluorouracil; Hepatic Artery; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Picibanil; Prognosis | 1984 |
[The present status of chemotherapy for hepatocellular carcinoma].
Topics: Administration, Oral; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Doxorubicin; Drug Delivery Systems; Fluorouracil; Humans; Infusion Pumps; Infusions, Intra-Arterial; Liver Neoplasms; Mitomycin; Survival Rate; Tegafur; Uracil | 1993 |